Exploring nalbuphine loaded chitosan nanoparticles for effective pain management through intranasal administration: a comparative study-Reference-Cited by-同舟云学术

Exploring nalbuphine loaded chitosan nanoparticles for effective pain management through intranasal administration: a comparative study

Published:2024-09-04 Issue: Volume: Page:1-12
ISSN:1061-186X
Container-title:Journal of Drug Targeting
language:en
Short-container-title:Journal of Drug Targeting

Author:

Khanna Kushagra¹²^ORCID,Sharma Nitin³^ORCID,Karwasra Ritu⁴,Kumar Abhishek⁵,Nishad Dhruv Kumar⁵,Janakiraman Ashok Kumar²^ORCID,Ram Mani Ravishankar²,Rajagopal Mogana²,Tayyab Saad²,Goel Bhawna⁶

Affiliation:

1. Department of Pharmaceutics, Delhi Pharmaceutical Science and Research University, New Delhi, India

2. Faculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur, Malaysia

3. Department of Pharmaceutics, Amity Institute of Pharmacy, Amity University, Noida, India

4. Central Council for Research in Unani Medicine (CCRUM), Ministry of AYUSH, Government of India, New Delhi, India

5. Institute of Nuclear Medicine & Allied Sciences, DRDO, New Delhi, India

6. Department of Pharmacy, School of Healthcare and Allied Sciences, GD Goenka University, Gurugram, India

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/1061186X.2024.2397800

Reference45 articles.

1. Intranasal solid lipid nanoparticles for management of pain: A full factorial design approach, characterization & Gamma Scintigraphy

2. Vitamin D and Its Potential Interplay With Pain Signaling Pathways

3. Comprehensive Review of Epidemiology, Scope, and Impact of Spinal Pain

4. Use of the mixed agonist–antagonist nalbuphine in opioid based analgesia

5. The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain